Prostate cancer is the most common type of solid tumor and a leading cause of cancer-related death of men living in the developed world. In recent years, the molecular mechanisms involved in prostate cancer development and/or progression have been intensely studied and several genes have been identified. TGIFLX/Y (TGIFLX and TGIFLY) are members of the homeobox superfamily of genes whose function(s) is unknown. To investigate TGIFLX/YmRNA expression in prostate cancer, we studied two different types of clinical samples, namely 60 prostate tumors and 15 cases of benign prostate hyperplasia (BPH), by RT-PCR. Our results revealed that most prostate tumors (73.5%) express at least one of these genes, although different patterns of TGIFLX/Y mRNA expression were observed. In some tumor samples the expression of both genes was detected, while in others no expression of either gene was observed. Notably, there was a significant correlation between expression of both TGIFLX and TGIFLY and a Gleason score of ≥6 (P = 0.038). By contrast, expression of TGIFLX/Y mRNA in BPH samples could not be detected. These results suggest an association of TGIFLX/Y expression with the progression of prostate cancer.
Introduction
Prostate cancer (PCa) is the most frequently diagnosed non-cutaneous malignancy and the second leading cause of cancer death of men living in the developed world [1] . Despite the identification of several genes that are important in PCa development, the molecular mechanisms that contribute to the onset or progression of PCa are not fully understood. One group of genes implicated in PCa are the homeobox genes, which encode transcription factors involved in the regulation of gene expression [2, 3, 4] , that function in normal and abnormal developmental processes [5, 6, 7] . They are categorized into six distinctive groups, one of which is the TALE (three amino acid loop extension) class. Like other homeobox classes, TALE proteins possess a helix-turn-helix DNA binding motif known as the homeodomain and act to regulate various cellular processes by specifically binding to the transcriptional control regions of target genes [8, 9, 10] .
TGIF (TG-interacting factor) is a TALE-class homeodomain protein that serves as a multifunctional repressor of TGF beta-induced transcription. The related TGIF2 shows distinct homology with TGIF and is ubiquitously expressed in human tissues, with the highest levels being found in heart, kidney, and testis as well as in ovarian cancer cells [11, 12] . TGIF-like homeodomain proteins are those that have homology with TGIF. TGIFLX/Y is a homeobox locus related to the TALE superclass gene family and consists of two genes: TGIFLX (X-linked) and TGIFLY (Y-linked). TGIFLX, which is thought to have originated from the retrotransposition of TGIF2 [reference] , is 2808 bp in length and comprises two exons, with the coding region being located within exon 2. In spite of the fact that TGIFLY shows a remarkable similarity to TGIFLX, a single nucleotide deletion in codon 149 of TGIFLYproduces a frameshift that leads to a truncated protein (56 amino acids shorter than TGIFLX). The biological roles of TGIFLX/Y remain poorly understood, although both these genes are specifically expressed in human adult testis [13] . Consistent with this, we recently reported an association of TGIFLX/Y mRNA expression with azoospermia in infertile men [14] . An accumulating body of data also suggests a possible involvement of this class of homeobox gene in malignant transformation. In the present study, therefore, we investigated whether the expression of TGIFLX and TGIFLY may be associated with human PCa. We utilized the RT-PCR technique to examine TGIFLX and TGIFLY mRNA expression in both PCa and benign prostatic hyperplasia (BPH).
Materials and methods

Subjects
The study group consisted of 60 previously untreated PCa patients with known histological information and 15 age-matched patients with untreated BPH. Indication for PCa and BPH was elevated serum levels of prostate-specific antigen (PSA), and further diagnosis was made by transrectal ultrasound (TRUS)-guided biopsies. Pathological examination confirmed the presence of cancerous cells or benign hyperplasias. For all patients, relevant clinical and pathological data were collected.
Tissue collection and RNA extraction Tissue samples from patients were collected at Imam Khomeini Hospital and Bistoon Ultrasound Clinic, immediately placed in liquid nitrogen and carried to the laboratory for either total RNA isolation or storage at −70°C. Informed consent was obtained from all the participants in this study. During serial slide preparation samples were homogenized according to the microscopic characteristics of cancerous cells with more than 80% of cells that underwent RNA extraction. Tripure isolation reagent (Roche, Mannheim, Germany) was used for extraction of total RNA according to the manufacturer's instructions with minor modifications. Briefly, the tumor specimen was homogenized in Tripure reagent, mixed with chloroform, then shaken vigorously for 15 s and centrifuged at 12,000g for 15 min at 4°C. The RNA present in the upper colorless aqueous phase was precipitated by addition of isopropanol, washed with 75% ethanol, air-dried, and then dissolved in RNase-free water. Following incubation for 10 min at 55°C to allow for complete dissolution, the RNA was stored at −70°C.
cDNA synthesis and RT-PCR
For the synthesis of cDNA 1 μg of total RNA was added to a master mix that included 4 μl of 5× reverse transcriptase (RT) buffer (Fermentas, Burlington, Canada) 10 mM of each dNTP, 20 pmol/μl random primer, 20 U RNase inhibitor (Roche, Mannheim, Germany), 200 U Moloney Murine Leukemia Virus (M-MuLV) RT (RevertAid TM , Fermentas, Burlington, Canada), and 4 μl of DEPCtreated water. The RT reaction was performed at 42°C for 60 min, followed by heat inactivation at 70°C for 10 min. The integrity of cDNA was checked using the housekeeping gene phosphoglucomutase 1 (PGM1) primers, which amplify the region 1718-2104 (from exon 10 to exon 11). The sequences of the used forward and reverse primers are: PGMF: 5′-GCCCGCAGGTCCTCTTTCCCTCACA-3′ and PGMR 5′-TCCGACTGAGCGGCACTGGGAGTGC-3′. Samples with satisfactory cDNA quality as judged by the PGM1 PCR were stored at −20°C for subsequent investigation. Differential expression of TGIFLX and TGIFLY in PCa tissues was carried out by amplification refractory mutation system RT-PCR. Briefly, a specific common forward primer corresponding to the 5′ untranslated region of both the TGIFLX and TGIFLY transcribed sequences (5′-TCGAAACAACAGTAACGATAAGCCT-3′) was used with gene-specific reverse primers 5′-CATTGATAAACCAGTTAGAAATCT-3′ for TGIFLX and to 5′-CATTGATAAACCAGTTAGAAATCC-3′ for TGIFLY. Thermocycling was performed using a Touch-down amplification program on an ABI thermocycler. The PCR conditions included an initial denaturation step for 3 min at 95°C, 30 s at 95°C, 45 s at 64°C with a 1°C decrease every second cycle down to 55°C, then 55°C for 14 cycles, 1 min at 72°C for extension, and finally 10 min at 72°C. PCR products were separated on 2% agarose gels and visualized with ethidium bromide. Positive controls for all RT-PCR assays were carried out using PGM1 and the specificity of TGIFLX/Y primers was tested using genomic DNA (gDNA).
Statistical analysis
Microsoft Excel spreadsheet and the Statistical Package for Social Sciences (SPSS) version 11.2 were used for data entry and analysis. Correlations between TGIFLX/Y mRNA expression and Gleason score were examined using the Fisher test and an alpha level of 0.05 was used to indicate statistical significance.
Results
TGIFLX/Y mRNA expression in prostate cancer and BPH biopsy
Sixty PCa patient's, relevant clinical and pathological data were collected and showed that 13.4%, 58.3%, and 28.3% of prostate cancer patients represented Gleason scores with (4-5), (6-7), and (8-10), respectively. To examine the expression of TGIFLX and TGIFLY in human PCa, total RNA was obtained from 60 PCa tumors as well as 15 BPH specimens. The principal characteristics of these study populations are presented in Table 1 . In the first instance, we confirmed RNA quality by RT-PCR for PGM1 gene expression and representative results of four PCa tumors are shown in Fig. 1 . A survey of TGIFLX and TGIFLY expression revealed that, whereas most PCa specimens (73.5%) contained transcripts from at least one of these genes (Table 2, Fig. 2 ), neither gene was expressed in cases of BPH (data not shown).
The expression of TGIFLX and TGIFLY showed different patterns among the various PCa patients (Table 2) . TGIFLY was expressed in 36 out of 60 (60%) and TGIFLX expression in 31 out of 60 (51.6%) cases. When the expression of both genes was analyzed, 38.3% patients were positive for both genes, 21.6% had only TGIFLY expression and were negative for TGIFLXgene, 13.3% showed TGIFLX expression only, and 26.6% had no expression of either gene.
Expression of TGIFLX/Y is associated with higher-grade prostate cancer
We analyzed the correlation between TGIFLX/Y gene expression and Gleason score in the PCa specimens by SPSS and Fisher's exact test for each of the genes ( 
Discussion
Several studies have demonstrated that heterogeneity increases markedly with progression from benign prostate hyperplasia through prostatic intraepithelial neoplasia (PIN) to localized PCa and metastases [15] . By using a genome-wide scan, several candidate genes have been identified for malignant transformation in the prostate [16, 17, 18] .
In a previous gene expression study, we identified an association between human homeobox TGIFLX/Y mRNA expression with azoospermia in men [14] . The TGIFLX/Y gene is a member of TALE group of homeobox genes, which is specifically expressed in human adult testis [13] . In male infertility, TGIFLX/Y has been implicated in the azoospermia phenotype [14] . The results of the present work show a significant correlation between TGIFLX/Y gene expression and Gleason score in prostate cancer. The TGIFLX/Y gene is not the first homeobox gene to be implicated in the development of prostate cancer. Aberrant HOXC8 expression was reported in human prostate tumors where it was associated with loss of differentiation [19] . Subsequently, Miller et al. [20] found overexpression of four HOXC cluster genes (HOXC4, HOXC5, HOXC6, and HOXC8 ) in malignant prostate cell lines and lymph node metastases using RT-PCR. By RT-PCR, we detected the expression of both TGIFLX and TGIFLY in 23 out of 60 (38.3%) prostate tumors, but not in BPH samples. This dysregulation points to a possible involvement of TGIFLX/Y expression with malignancy in prostate cells.
The expression patterns of HOX genes, which are normally expressed in proliferating and/or differentiated tissues, are often different in comparison to cancerous cells [17, 21] . This reflects the now well established view that HOX genes can play a role in the process of carcinogenesis by acting in different pathways [22, 23] . In several cancers, HOX genes function by either gain or loss of expression, which is associated with their oncogene-like or tumor suppressor-like activities, respectively. The loss-of-function of the NKX3.1 homeobox gene is an important example of the latter in respect to prostate cancer. Since TGIFLX/Y gene expression is normally lacking in the prostate, its presence can be categorized as a "gain" of expression in prostate cancer. Although different patterns of TGIFLX/Y mRNA expression in PCa biopsies could be due to genetic heterogeneity, our results suggest that TGIFLX/Y may have a role in cancer development, especially since mRNA expression of TGIFLX and TGIFLYwere not detected among BPH samples.
Significantly, expression of TGIFLX/Y genes was associated with a Gleason score of ≥6. Other genes whose aberrant expression have been reported to be associated with a higher Gleason score in prostate cancer include HOXC8 [19] , E-cadherin [17, 24] , and DNp73 [25] , a p53 homologue that induces apoptosis and inhibits cell proliferation in benign and malignant tumors of the prostate. Our results suggest interactive effects between the TGIFLX and TGIFLY genes in prostate cancer progression. However, it is also possible that TGIFLX and TGIFLY act as redundant regulatory proteins, at least in the context of their abnormal function in tumor development. Several studies have reported redundancy between some homeobox genes [26, 27, 28] . The best examples to date are two nearly identical homeobox genes of the TGIF subclass, vismay and achinta (vis/achi), in Drosophila melanogaster that are normally expressed in the testes. Wang and Mann [28] indicated that Vis and Achi are redundant transcriptional regulators that function at the same step in normal sperm development. Thus, it remains a possibility that expression of either the TGIFLX or TGIFLYgenes could have a role malignancy.
In conclusion, our results indicate a significant correlation between prostate cancer and the abnormal expression of the TGIFLX and TGIFLY genes. Nevertheless, the precise mechanisms by which these genes are involved in tumorigenesis remain to be elucidated. The use of specific antibodies for precise quantification and localization, together with measurement of interaction with other proteins, will be a first step in addressing the direct or indirect involvement of the TGIFLX/Y genes in normal and abnormal biological functions. 
